Polarean Imaging plc
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent ind… Read more
Polarean Imaging plc (PLLWF) - Net Assets
Latest net assets as of June 2025: $7.90 Million USD
Based on the latest financial reports, Polarean Imaging plc (PLLWF) has net assets worth $7.90 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.09 Million) and total liabilities ($3.19 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $7.90 Million |
| % of Total Assets | 71.26% |
| Annual Growth Rate | N/A |
| 5-Year Change | 39.04% |
| 10-Year Change | 1589.37% |
| Growth Volatility | 127.33 |
Polarean Imaging plc - Net Assets Trend (2014–2024)
This chart illustrates how Polarean Imaging plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Polarean Imaging plc (2014–2024)
The table below shows the annual net assets of Polarean Imaging plc from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $12.14 Million | +46.32% |
| 2023-12-31 | $8.30 Million | -57.01% |
| 2022-12-31 | $19.30 Million | -39.17% |
| 2021-12-31 | $31.74 Million | +263.41% |
| 2020-12-31 | $8.73 Million | +90.27% |
| 2019-12-31 | $4.59 Million | -41.09% |
| 2018-12-31 | $7.79 Million | +126.47% |
| 2017-12-31 | $3.44 Million | +687.35% |
| 2016-12-31 | $-585.75K | -181.49% |
| 2015-12-31 | $718.76K | +261.46% |
| 2014-12-31 | $-445.16K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Polarean Imaging plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7252070400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $570.34K | 4.70% |
| Other Comprehensive Income | $14.25 Million | 117.38% |
| Other Components | $70.51 Million | 580.68% |
| Total Equity | $12.14 Million | 100.00% |
Polarean Imaging plc Competitors by Market Cap
The table below lists competitors of Polarean Imaging plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eumundi Group Ltd
AU:EBG
|
$7.97 Million |
|
Eduspec Holdings Bhd
KLSE:0107
|
$7.97 Million |
|
Crest Group Berhad
KLSE:0323
|
$7.97 Million |
|
Paragon Technologies Inc
PINK:PGNT
|
$7.97 Million |
|
Comvex SA
RO:CMVX
|
$7.96 Million |
|
Pesona Metro Holdings Bhd
KLSE:8311
|
$7.96 Million |
|
SavMobi Technology Inc.
PINK:SVMB
|
$7.96 Million |
|
Delko S.A.
WAR:DEL
|
$7.96 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Polarean Imaging plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,298,444 to 12,142,605, a change of 3,844,161 (46.3%).
- Net loss of 8,539,972 reduced equity.
- New share issuances of 12,578,433 increased equity.
- Other comprehensive income increased equity by 713,895.
- Other factors decreased equity by 908,195.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-8.54 Million | -70.33% |
| Share Issuances | $12.58 Million | +103.59% |
| Other Comprehensive Income | $713.89K | +5.88% |
| Other Changes | $-908.20K | -7.48% |
| Total Change | $- | 46.32% |
Book Value vs Market Value Analysis
This analysis compares Polarean Imaging plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.89x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $-0.88 | $0.02 | x |
| 2015-12-31 | $0.50 | $0.02 | x |
| 2016-12-31 | $-0.55 | $0.02 | x |
| 2017-12-31 | $0.12 | $0.02 | x |
| 2018-12-31 | $0.11 | $0.02 | x |
| 2019-12-31 | $0.04 | $0.02 | x |
| 2020-12-31 | $0.06 | $0.02 | x |
| 2021-12-31 | $0.16 | $0.02 | x |
| 2022-12-31 | $0.09 | $0.02 | x |
| 2023-12-31 | $0.04 | $0.02 | x |
| 2024-12-31 | $0.01 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Polarean Imaging plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -70.33%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -276.38%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 1.30x
- Recent ROE (-70.33%) is above the historical average (-92.84%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | -11.33% | 1.18x | 0.00x | $-54.33K |
| 2015 | -298.61% | -118.66% | 0.61x | 4.15x | $-1.11 Million |
| 2016 | 0.00% | -120.33% | 1.86x | 0.00x | $-1.00 Million |
| 2017 | -115.04% | -319.91% | 0.18x | 1.97x | $-4.30 Million |
| 2018 | -70.01% | -223.63% | 0.25x | 1.26x | $-6.23 Million |
| 2019 | -132.97% | -265.24% | 0.33x | 1.53x | $-6.56 Million |
| 2020 | -74.82% | -618.35% | 0.10x | 1.25x | $-7.41 Million |
| 2021 | -44.16% | -1182.36% | 0.03x | 1.09x | $-17.19 Million |
| 2022 | -72.03% | -1346.13% | 0.05x | 1.17x | $-15.84 Million |
| 2023 | -143.22% | -1333.97% | 0.08x | 1.31x | $-12.71 Million |
| 2024 | -70.33% | -276.38% | 0.20x | 1.30x | $-9.75 Million |
Industry Comparison
This section compares Polarean Imaging plc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Polarean Imaging plc (PLLWF) | $7.90 Million | 0.00% | 0.40x | $7.97 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |